Literature DB >> 20436499

Pathology evaluation of sentinel lymph nodes in breast cancer: protocol recommendations and rationale.

Donald L Weaver1.   

Abstract

Sentinel lymph nodes (SLN) are more likely to contain metastatic breast carcinoma than non-SLNs. The limited number of SLNs compared with an axillary dissection has prompted more comprehensive lymph node analysis increasing detection of micrometastases. National data show that many women previously classified node negative are now classified minimally node positive. As a result, our nodal classification and cancer staging have evolved to recognize the continuum of nodal tumor burden rather than a simplistic dichotomous stratification. It is quite clear that the more sections we evaluate from SLNs the more metastases we identify; however, it is impractical to expect the practicing pathologist to mount, stain, and microscopically examine every section through the SLN paraffin blocks. Despite recommendations from the College of American Pathologists and the American Society of Clinical Oncology, heterogeneity in the approach to SLN evaluation exists. What is needed is adherence to a standardized evaluation protocol. The most important aspect of the sentinel node examination is careful attention to slicing the SLN no thicker than 2.0 mm and correct embedding of the slices to assure we identify all macrometastases larger than 2.0 mm. A single section from blocks prepared in this manner will identify all macrometastases present but smaller metastases will be missed. The prognostic significance of these missed micrometastases is still being evaluated as we await SLN outcome studies. In the context of the new molecular classification of breast cancer, subgroups may be identified where detection of micrometastases has clinical significance. It is critical that both clinicians and pathologists understand there is a random component to micrometastasis distribution within the three-dimensional paraffin tissue blocks. If we ultimately adopt more comprehensive microscopic evaluation of SLNs, the candidate sampling strategies need to be carefully considered in the context of statistically valid sampling strategies.

Entities:  

Mesh:

Year:  2010        PMID: 20436499     DOI: 10.1038/modpathol.2010.36

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  34 in total

1.  Impact of Micrometastatic Axillary Nodes on Survival of Breast Cancer Patients with Tumors ≤2 cm.

Authors:  Hyeon Woo Bae; Kwang Hyun Yoon; Joo Heung Kim; Sung Mook Lim; Jee Ye Kim; Hyung Seok Park; Seho Park; Seung Il Kim; Young Up Cho; Byeong-Woo Park
Journal:  World J Surg       Date:  2018-12       Impact factor: 3.352

2.  Survival of tumor and normal cells upon targeting with electron-emitting radionuclides.

Authors:  Didier Rajon; Wesley E Bolch; Roger W Howell
Journal:  Med Phys       Date:  2013-01       Impact factor: 4.071

3.  Alterations of high endothelial venules in primary and metastatic tumors are correlated with lymph node metastasis of oral and pharyngeal carcinoma.

Authors:  Hui Shen; Xiang Wang; Zhe Shao; Ke Liu; Xiao-Yan Xia; Han-Zhong Zhang; Kai Song; Yong Song; Zheng-Jun Shang
Journal:  Cancer Biol Ther       Date:  2013-12-18       Impact factor: 4.742

Review 4.  Sentinel Lymph Nodes for Breast Carcinoma: A Paradigm Shift.

Authors:  Aoife Maguire; Edi Brogi
Journal:  Arch Pathol Lab Med       Date:  2016-08       Impact factor: 5.534

5.  Frozen section analysis of sentinel lymph nodes in patients with breast cancer does not impair the probability to detect lymph node metastases.

Authors:  Eva V E Madsen; Jan van Dalen; Joost van Gorp; Poultje M P van Oort; Thijs van Dalen
Journal:  Virchows Arch       Date:  2011-11-25       Impact factor: 4.064

6.  Clinical Implications of Micrometastasis Detection in Internal Mammary Nodes of Breast Cancer Patients.

Authors:  Jian Zeng; Huazhi Xie; Yunfei Lu; Zhenbo Feng; Fu Li
Journal:  Breast Care (Basel)       Date:  2012-06-22       Impact factor: 2.860

7.  Positive Lymph Node Counts in American Thyroid Association Low-Risk Papillary Thyroid Carcinoma Patients.

Authors:  Martha J Griffin; Fred M Baik; Margaret Brandwein-Weber; Muhammad Qazi; Lauren E Yue; Marcela Osorio; Mark L Urken
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

8.  In breast cancer patients sentinel lymph node metastasis characteristics predict further axillary involvement.

Authors:  Ildiko Illyes; Anna-Maria Tokes; Attila Kovacs; A Marcell Szasz; Bela A Molnar; Istvan A Molnar; Ilona Kaszas; Zsuzsanna Baranyak; Zsolt Laszlo; Istvan Kenessey; Janina Kulka
Journal:  Virchows Arch       Date:  2014-05-09       Impact factor: 4.064

9.  Eight-year experience with the intraoperative frozen section examination of sentinel lymph node biopsy for breast cancer in a North-Italian university center.

Authors:  Carla Cedolini; Serena Bertozzi; Luca Seriau; Ambrogio P Londero; Serena Concina; Federico Cattin; Onelio Geatti; Carla Di Loreto; Andrea Risaliti
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

Review 10.  Sentinel lymph nodes for breast carcinoma: an update on current practice.

Authors:  Aoife Maguire; Edi Brogi
Journal:  Histopathology       Date:  2016-01       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.